Cannabis  March 1, 2021

Charlotte’s Web, Harvard researcher to partner on CBD study

BOULDER —Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) announced late last month the launch of clinical trials studying the potential health benefits of CBD involving the company, McLean Hospital in Massachusetts and Harvard University professor Staci Gruber.

Gruber leads McLean’s Marijuana Investigations for Neuroscientific Discovery (MIND) Program.

“We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials,” Tim Orr, president of Charlotte’s Web’s CW Labs division, said in a prepared statement. “Charlotte’s Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country’s top scientists.”

© 2021 BizWest Media LLC

BOULDER —Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) announced late last month the launch of clinical trials studying the potential health benefits of CBD involving the company, McLean Hospital in Massachusetts and Harvard University professor Staci Gruber.

Gruber leads McLean’s Marijuana Investigations for Neuroscientific Discovery (MIND) Program.

“We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials,” Tim Orr, president of Charlotte’s Web’s CW Labs division, said in a prepared statement. “Charlotte’s Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country’s top scientists.”

© 2021…

Sign up for BizWest Daily Alerts